Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

BIT:ENAV
BIT:ENAVInfrastructure

A Fresh Look at ENAV (BIT:ENAV) Valuation After Upgraded Outlook and Record Flight Growth

ENAV (BIT:ENAV) just delivered its nine-month 2025 earnings update, highlighting growth in both air traffic and revenue. The company handled record flights, confirmed its upgraded outlook, and maintained strong performance amid regulatory changes. See our latest analysis for ENAV. On the heels of record traffic and raised guidance, ENAV’s share price has gained 10.2% year-to-date. This reflects building momentum as investors warm to its improving financial outlook. With a 27.2% total return...
ASX:DUR
ASX:DURConstruction

3 ASX Stocks That Could Be Trading Below Their Estimated Value In November 2025

As the Australian market experiences a mixed performance with commodities like lithium gaining traction and technology stocks facing headwinds, investors are keenly observing potential opportunities amidst these fluctuations. In such an environment, identifying undervalued stocks becomes crucial, as they offer the possibility of growth when market conditions stabilize or improve.
NasdaqGS:OM
NasdaqGS:OMMedical Equipment

Could Tablo’s Real-World Success Shift Outset Medical’s (OM) Growth Trajectory Despite Lowered Guidance?

Outset Medical recently reported third quarter results, showing revenue of US$29.43 million and a reduced net loss of US$17.84 million compared to the previous year, while also lowering its annual revenue guidance for 2025. New research presented at the American Society of Nephrology's 2025 Kidney Week highlighted strong real-world outcomes for the Tablo system, including a large reduction in complications and high staff satisfaction across 1 million treatments in approximately 750...
ENXTLS:COR
ENXTLS:CORPackaging

Is Corticeira Amorim (ENXTLS:COR) Undervalued After Reporting Lower Nine-Month Sales and Earnings?

Corticeira Amorim (ENXTLS:COR) has just released its earnings for the nine months ending September 2025, reporting lower figures for both sales and net income when compared to last year. This update provides investors with new insights into ongoing profitability trends. See our latest analysis for Corticeira Amorim S.G.P.S. This earnings update comes against a backdrop of fading share price momentum for Corticeira Amorim S.G.P.S. The latest share price is $6.62, with a year-to-date share...
ENXTPA:IPN
ENXTPA:IPNPharmaceuticals

How Investors May Respond To Ipsen (ENXTPA:IPN) Positive Long-Term IQIRVO Data in PBC Trial

Recently, Ipsen presented late-breaking data from the ELATIVE trial at the AASLD Liver Meeting 2025 in Washington, revealing that IQIRVO® showed sustained biochemical response, stabilization of fibrosis markers, and notable symptom improvements over more than three years in primary biliary cholangitis patients. Further analysis indicated that IQIRVO may influence fatigue-related mitochondrial pathways, suggesting the treatment's potential long-term impact on disease progression and patient...
BME:ELE
BME:ELEElectric Utilities

How Investors May Respond To Endesa (BME:ELE) Lifting Net Income Outlook for 2025

On October 29, 2025, Endesa, S.A. confirmed its full-year 2025 earnings guidance, stating it expects net income to reach the upper end of its previously forecast range. This update signals strengthened management confidence in Endesa's financial outlook and operational progress against its strategic targets for the year. Let's examine how Endesa's raised earnings guidance shapes expectations for its long-term profitability and growth outlook. Trump's oil boom is here - pipelines are primed...
BIT:REC
BIT:RECPharmaceuticals

A Fresh Look at Recordati (BIT:REC) Valuation Following Earnings, Dividend, and Reaffirmed Growth Guidance

Recordati Industria Chimica e Farmaceutica (BIT:REC) has had a busy week, announcing third quarter earnings, reaffirming growth targets through 2027, and approving an interim dividend for shareholders. The company continues to show steady confidence in its direction. See our latest analysis for Recordati Industria Chimica e Farmaceutica. Recordati’s stock has shown quiet resilience lately, notching a 3.67% gain in the past day and a 4.83% total return over the last year. The recent...
NYSE:SPR
NYSE:SPRAerospace & Defense

The Bull Case For Spirit AeroSystems (SPR) Could Change Following Wider Losses Despite Higher Q3 Sales

Spirit AeroSystems Holdings reported third quarter 2025 earnings, showing sales rose to US$1,585.4 million while net losses increased to US$724.3 million, compared to a year ago. Despite higher sales both in the quarter and over nine months, the company’s net losses widened materially, highlighting ongoing cost or margin pressures. We’ll examine how the bigger net losses, despite higher sales, are shaping Spirit AeroSystems Holdings’ current investment narrative. Uncover the next big thing...
ENXTAM:BNJ
ENXTAM:BNJEntertainment

Do Delayed Revenues at Banijay Group (ENXTAM:BNJ) Reveal a Shift in Long-Term Growth Focus?

Banijay Group N.V. recently reported its earnings for the nine months ended September 30, 2025, showing sales of €3.22 billion and net income of €118.7 million, along with an update on annual guidance pointing to low-single digit growth in Entertainment & Live and around 10% growth at Banijay Gaming following a temporary hit from adverse sports results. An important detail emerging from these announcements is the company's decision to postpone some content deliveries to early 2026, paired...
BIT:TEN
BIT:TENEnergy Services

What Tenaris (BIT:TEN)'s Dividend Hike and Q3 Earnings Reveal About Profitability in Shifting Markets

Tenaris S.A. recently reported third-quarter 2025 earnings, posting sales of US$2,978.14 million and net income of US$445.69 million, along with board approval of an interim dividend of US$0.29 per share to be paid on November 26, 2025. A closer look reveals that while nine-month sales decreased compared to last year, earnings per share from continuing operations showed a year-over-year increase, reflecting continued profitability amid shifting market conditions. With the interim dividend...
OTCPK:SNRE.Y
OTCPK:SNRE.YTelecom

How Sunrise Communications’ (SNRE.Y) Focus on Cost-Cutting Has Narrowed Losses and Shifted Its Investment Story

On November 10, 2025, Sunrise Communications AG announced its third quarter and nine-month earnings, reporting third quarter sales of CHF 740.9 million and a net loss of CHF 5.4 million, both improving compared to prior year periods. While sales declined slightly year over year, the company narrowed its net loss substantially, highlighting progress in cost management and operational efficiency. We will explore how the company's sharp reduction in net losses may reshape Sunrise...